Literature DB >> 36074144

[New treatment concepts and combination therapies for cutaneous T-cell lymphomas].

Chalid Assaf1,2, Gabor Dobos3.   

Abstract

Primary cutaneous T‑cell lymphomas are a heterogeneous group of rare diseases. Patients often suffer from visible, severely pruritic skin lesions, infections, relapses, and their life expectancy may be reduced. Under current therapies, long-lasting, complete remission is rare. However, new treatment approaches and combination therapies are changing the future. Here, we provide an overview on this topic.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  CTCL; Immunotherapy; Low-dose radiotherapy; Mycosis fungoides; Primary cutaneous T‑cell lymphoma

Year:  2022        PMID： 36074144     DOI： 10.1007/s00105-022-05053-x

Source DB:  PubMed          Journal:  Dermatologie (Heidelb)        ISSN： 2731-7005


  18 in total

1.  Overall Survival in Mycosis Fungoides: A Systematic Review and Meta-Analysis.

Authors:  Ahmed Mourad; Robert Gniadecki
Journal:  J Invest Dermatol       Date:  2019-08-26       Impact factor: 8.551

2.  Low dose total skin electron beam therapy for the management of T cell cutaneous lymphomas.

Authors:  Ioannis Georgakopoulos; Evangelia Papadavid; Kalliopi Platoni; Amdromachi Kougioumtzopoulou; George Patatoukas; Efrosyni Kypraiou; Vasiliki Nikolaou; Efstathios Efstathopoulos; Nikolaos Kelekis; Vasilios Kouloulias
Journal:  Dermatol Ther       Date:  2020-06-08       Impact factor: 2.851

3.  NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020.

Authors:  Neha Mehta-Shah; Steven M Horwitz; Stephen Ansell; Weiyun Z Ai; Jeffrey Barnes; Stefan K Barta; Mark W Clemens; Ahmet Dogan; Kristopher Fisher; Aaron M Goodman; Gaurav Goyal; Joan Guitart; Ahmad Halwani; Bradley M Haverkos; Richard T Hoppe; Eric Jacobsen; Deepa Jagadeesh; Matthew A Lunning; Amitkumar Mehta; Elise A Olsen; Barbara Pro; Saurabh A Rajguru; Satish Shanbhag; Aaron Shaver; Andrei Shustov; Lubomir Sokol; Pallawi Torka; Carlos Torres-Cabala; Ryan Wilcox; Basem M William; Jasmine Zain; Mary A Dwyer; Hema Sundar; Youn H Kim
Journal:  J Natl Compr Canc Netw       Date:  2020-05       Impact factor: 11.908

4.  Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy.

Authors:  Charlotte F M Hughes; Amit Khot; Christopher McCormack; Stephen Lade; David A Westerman; Robert Twigger; Odette Buelens; Kate Newland; Constantine Tam; Michael Dickinson; Gail Ryan; David Ritchie; Colin Wood; H Miles Prince
Journal:  Blood       Date:  2014-10-21       Impact factor: 22.113

5.  Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry.

Authors:  G Dobos; A de Masson; C Ram-Wolff; M Beylot-Barry; A Pham-Ledard; N Ortonne; S Ingen-Housz-Oro; M Battistella; M d'Incan; J Rouanet; F Franck; M D Vignon-Pennamen; N Franck; A Carlotti; S Boulinguez; L Lamant; T Petrella; S Dalac; P Joly; P Courville; J Rivet; O Dereure; F Amatore; S Taix; F Grange; A Durlach; G Quéreux; N Josselin; I Moulonguet; L Mortier; R Dubois; E Maubec; L Laroche; L Michel; I Templier; S Barete; C Nardin; O Augereau; B Vergier; M Bagot
Journal:  Br J Dermatol       Date:  2020-11-29       Impact factor: 9.302

Review 6.  Chlormethin-Gel zur Behandlung der Mycosis fungoides: Ein Expertenkonsens aus Deutschland, Österreich und der Schweiz (DACH-Region) zum Therapiemanagement.

Authors:  Chalid Assaf; Nina Booken; Edgar Dippel; Emmanuella Guenova; Constanze Jonak; Claus-Detlev Klemke; Jan P Nicolay; Max Schlaak; Marion Wobser; Franz Trautinger
Journal:  J Dtsch Dermatol Ges       Date:  2022-05       Impact factor: 5.584

7.  Versorgungsstruktur der Patienten mit Mycosis fungoides und Sézary-Syndrom in Deutschland - Versorgungsforschung auf Basis von GKV-Routinedaten.

Authors:  Chalid Assaf; Gabor Dobos; Immo-Maximilian Zech; Axel Doess; Thomas Hibbe; Janusz J Jadasz
Journal:  J Dtsch Dermatol Ges       Date:  2022-05       Impact factor: 5.584

Review 8.  Emerging drugs for the treatment of cutaneous T-cell lymphoma.

Authors:  Melissa Cheng; Jasmine Zain; Steven T Rosen; Christiane Querfeld
Journal:  Expert Opin Emerg Drugs       Date:  2022-03-08       Impact factor: 3.912

9.  S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021.

Authors:  Edgar Dippel; Chalid Assaf; Jürgen C Becker; Michael von Bergwelt-Baildon; Sophie Bernreiter; Antonio Cozzio; Hans T Eich; Khaled Elsayad; Markus Follmann; Stephan Grabbe; Uwe Hillen; Wolfram Klapper; Claus-Detlev Klemke; Carmen Loquai; Frank Meiss; Christina Mitteldorf; Ulrike Wehkamp; Dorothee Nashan; Jan P Nicolay; Ilske Oschlies; Max Schlaak; René Stranzenbach; Rose Moritz; Christoph Stoll; Tibor Vag; Michael Weichenthal; Marion Wobser; Rudolf Stadler
Journal:  J Dtsch Dermatol Ges       Date:  2022-04       Impact factor: 5.231
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.